Wootten D, Reynolds CA, Smith KJ et al (2016) The extracellular surface of the GLP-1 receptor is a molecular trigger for biased agonism
Because theyre unregulated, their safety isnt guaranteed, and they come with a risk of skin irritation and hidden ingredients
It's the faster pace of weight loss that occurs with GLP-1 drugs that can make facial changes more obvious
However, despite the Food and Drug Administration recently raising concerns about the side effects of unapproved GLP-1s for weight loss, one-third of GLP-1 users have switched from brand-name to compounded or custom-mixed drugs
Possible drug interactions include: Alcohol may increase the risk of lactic acidosis (Janumet) Carbonic anhydrase inhibitors such as topiramate, zonisamide, acetazolamide or dichlorphenamide may increase the risk of lactic acidosis (Janumet) Digoxin (Januvia) Insulin may increase the risk of low blood sugar (Januvia and Janumet) Share This Page: Who Am I Calling
Is the AI estimate perfect